Coronary-prone behaviour pattern and coronary heart disease: implications for the use of beta-blockers in primary prevention.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D001161:Arteriosclerosis / Q000209:etiology; D001519:Behavior; D001521:Behavior Therapy; D002395:Catecholamines / Q000378:metabolism; D003327:Coronary Disease / Q000517:prevention & control / Q000523:psychology*; D005260:Female; D005639:Frustration; D006801:Humans; D006973:Hypertension / Q000150:complications; D008297:Male; D011322:Primary Prevention; D012083:Renin / Q000097:blood
D000319:Adrenergic beta-Antagonists; D002395:Catecholamines; D012083:Renin